| # | Title | Journal | Year | Citations |
|---|
| 1 | Effect of Essential Oils on Pathogenic Bacteria | Pharmaceuticals | 2013 | 1,256 |
| 2 | Antimicrobial Peptides | Pharmaceuticals | 2013 | 1,003 |
| 3 | The Therapeutic Potential of Naringenin: A Review of Clinical Trials | Pharmaceuticals | 2019 | 470 |
| 4 | Human Antimicrobial Peptides and Proteins | Pharmaceuticals | 2014 | 402 |
| 5 | Essential Oils and Antifungal Activity | Pharmaceuticals | 2017 | 394 |
| 6 | Antimicrobial Peptides from Plants | Pharmaceuticals | 2015 | 343 |
| 7 | Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer | Pharmaceuticals | 2014 | 323 |
| 8 | Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges | Pharmaceuticals | 2012 | 316 |
| 9 | Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth | Pharmaceuticals | 2019 | 283 |
| 10 | Clinical Toxicities of Histone Deacetylase Inhibitors | Pharmaceuticals | 2010 | 281 |
| 11 | Antimicrobial Peptides Targeting Gram-Positive Bacteria | Pharmaceuticals | 2016 | 270 |
| 12 | Methods of Synthesis, Properties and Biomedical Applications of CuO Nanoparticles | Pharmaceuticals | 2016 | 257 |
| 13 | Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems | Pharmaceuticals | 2010 | 255 |
| 14 | Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production | Pharmaceuticals | 2013 | 254 |
| 15 | Antimicrobial Peptides from Fish | Pharmaceuticals | 2014 | 246 |
| 16 | Cobalt Complexes as Antiviral and Antibacterial Agents | Pharmaceuticals | 2010 | 235 |
| 17 | Glioblastoma Multiforme Therapy and Mechanisms of Resistance | Pharmaceuticals | 2013 | 229 |
| 18 | Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy | Pharmaceuticals | 2019 | 218 |
| 19 | Old Drugs as New Treatments for Neurodegenerative Diseases | Pharmaceuticals | 2018 | 213 |
| 20 | Antibody–Drug Conjugates: The Last Decade | Pharmaceuticals | 2020 | 207 |
| 21 | Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics | Pharmaceuticals | 2013 | 202 |
| 22 | Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy | Pharmaceuticals | 2010 | 200 |
| 23 | A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011 | Pharmaceuticals | 2013 | 199 |
| 24 | Roles of Heat Shock Proteins in Apoptosis, Oxidative Stress, Human Inflammatory Diseases, and Cancer | Pharmaceuticals | 2018 | 189 |
| 25 | Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review | Pharmaceuticals | 2020 | 187 |
| 26 | Gut Microbiota and Iron: The Crucial Actors in Health and Disease | Pharmaceuticals | 2018 | 186 |
| 27 | Heparin: Past, Present, and Future | Pharmaceuticals | 2016 | 181 |
| 28 | The Role of NCOA4-Mediated Ferritinophagy in Health and Disease | Pharmaceuticals | 2018 | 180 |
| 29 | The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs | Pharmaceuticals | 2020 | 180 |
| 30 | Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases | Pharmaceuticals | 2010 | 179 |
| 31 | Peptides and Peptidomimetics for Antimicrobial Drug Design | Pharmaceuticals | 2015 | 178 |
| 32 | FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver | Pharmaceuticals | 2013 | 176 |
| 33 | Nonsteroidal Anti-Inflammatory Drugs and the Kidney | Pharmaceuticals | 2010 | 175 |
| 34 | Inhaled Corticosteroids | Pharmaceuticals | 2010 | 173 |
| 35 | Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges | Pharmaceuticals | 2013 | 171 |
| 36 | The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments | Pharmaceuticals | 2010 | 168 |
| 37 | Antimicrobial Peptides in 2014 | Pharmaceuticals | 2015 | 168 |
| 38 | Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders | Pharmaceuticals | 2018 | 167 |
| 39 | Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress—Protective Activity | Pharmaceuticals | 2010 | 164 |
| 40 | Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications | Pharmaceuticals | 2018 | 161 |
| 41 | A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters? | Pharmaceuticals | 2015 | 160 |
| 42 | Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks | Pharmaceuticals | 2010 | 157 |
| 43 | Cannabidiol in Humans—The Quest for Therapeutic Targets | Pharmaceuticals | 2012 | 155 |
| 44 | Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases | Pharmaceuticals | 2014 | 152 |
| 45 | Lactoferrin from Milk: Nutraceutical and Pharmacological Properties | Pharmaceuticals | 2016 | 144 |
| 46 | Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity | Pharmaceuticals | 2020 | 142 |
| 47 | Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities | Pharmaceuticals | 2010 | 141 |
| 48 | Dendrimers for siRNA Delivery | Pharmaceuticals | 2013 | 135 |
| 49 | Impact of Glycosylation on Effector Functions of Therapeutic IgG | Pharmaceuticals | 2010 | 132 |
| 50 | Glycosaminoglycans and Proteoglycans | Pharmaceuticals | 2018 | 130 |
